Literature DB >> 2021997

Nimodipine decreases the minimum alveolar concentration of isoflurane in dogs.

A E Schwartz1, F R Maneksha, W W Backus, M S Kanchuger, W L Young.   

Abstract

Nimodipine is a calcium antagonist that binds with high affinity to neuronal membranes. It is a potent cerebrovasodilator and has been demonstrated also to affect neurotransmitter synthesis and release. Because patients undergoing surgery for intracranial aneurysms are frequently receiving nimodipine, the authors determined the MAC of isoflurane in six dogs before and during three infusion doses of nimodipine (0.5, 1.0 and 2.0 micrograms.kg-1.min-1). MAC was also determined in five dogs before and during infusion of the drug vehicle (10 microliters.kg-1.min-1). Nimodipine produced a reduction in MAC from 1.47 +/- 0.33% to 1.19 +/- 0.18, 1.15 +/- 0.18 and 1.15 +/- 0.09% during infusions of nimodipine 0.5, 1.0 and 2.0 micrograms.kg-1.min-1, respectively (P less than 0.05). Infusion of drug vehicle alone produced no change in MAC (1.39 +/- 0.15%). This reduction in anaesthetic requirement by nimodipine may be due to its effect on neurotransmission. Adjustments in anaesthetic dosage may be necessary in patients receiving nimodipine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021997     DOI: 10.1007/BF03008154

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  Multiple calcium channels mediate neurotransmitter release from peripheral neurons.

Authors:  T M Perney; L D Hirning; S E Leeman; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Prevention by nimodipine, a calcium entry blocker, of the effect of alpha 2-adrenoceptor blocking agents on noradrenaline release: differential effects of nimodipine, on [3H]noradrenaline and [14C]acetylcholine release measured concomitantly from the guinea-pig ileum.

Authors:  T Bartfai; E S Vizi
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-12

Review 3.  Pharmacological basis for the use of nimodipine in central nervous system disorders.

Authors:  A Scriabine; T Schuurman; J Traber
Journal:  FASEB J       Date:  1989-05       Impact factor: 5.191

4.  Verapamil decreases MAC for halothane in dogs.

Authors:  M Maze; D M Mason; R E Kates
Journal:  Anesthesiology       Date:  1983-10       Impact factor: 7.892

5.  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

Authors:  K C Petruk; M West; G Mohr; B K Weir; B G Benoit; F Gentili; L B Disney; M I Khan; M Grace; R O Holness
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

6.  Flumazenil decreases the minimum alveolar concentration isoflurane in dogs.

Authors:  A E Schwartz; F R Maneksha; M S Kanchuger; U S Sidhu; P J Poppers
Journal:  Anesthesiology       Date:  1989-05       Impact factor: 7.892

7.  Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736).

Authors:  O Nordström; S Braesch-Andersen; T Bartfai
Journal:  Acta Physiol Scand       Date:  1986-01

8.  Behavioral effects of nimodipine in animals.

Authors:  F Hoffmeister; U Benz; A Heise; H P Krause; V Neuser
Journal:  Arzneimittelforschung       Date:  1982

9.  In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain.

Authors:  E Pileblad; A Carlsson
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brain.

Authors:  E Pileblad; A Carlsson
Journal:  Neuropharmacology       Date:  1987-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.